期刊文献+

体外富集Treg细胞对CTL杀伤MNK45胃癌细胞活性的影响及机制研究 被引量:2

The influence of enriched CD4^+CD25^+ T regulatory cells on cytotoxic T lymphocytes killing MNK45 cells in vitro and its possible mechanism
暂未订购
导出
摘要 目的体外分析CD4+CD25+Treg(regulatory T cells)细胞对CD8+CTL(cytotoxic Tlym-phocytes)细胞杀伤MNK45胃癌细胞株活性的影响及机制。方法通过T细胞纯化柱分选小鼠脾细胞悬液T淋巴细胞,以MACS单阳性和双阳性分选法分别富集CD4+CD25+Treg细胞和CD8+CTL;通过不同浓度CD8+CTL与MNK45胃癌细胞混合培养,筛选有效杀瘤体外培养体系。通过Trans Well分隔培养和混合培养的方式向CTL与MNK45胃癌细胞株组成的体外抗肿瘤培养体系中加入CD4+CD25+Treg细胞,以瑞氏染色显微计数的方法观察Treg细胞对CTL杀伤MNK45胃癌细胞活性的影响,结合ELISA法检测各体系穿孔素浓度,分析影响活性的细胞及免疫学机制。结果质量浓度为2.0×105/ml的CTL与1.0×105/ml MNK45胃癌细胞混合培养,CTL能对MNK45胃癌细胞形成明显的杀伤作用(P<0.01);在此培养体系中以混合培养的方式加入质量浓度为5.0×104/ml CD4+CD25+Treg细胞即可明显抑制培养体系中CTL对肿瘤细胞的杀伤作用;如以Trans Well分隔培养的方式将CD4+CD25+Treg细胞与抗肿瘤培养体系分隔培养,达到同样抑制效能(实验组死亡肿瘤细胞百分率与对照组比较,P<0.05)的CD4+CD25+Treg细胞浓度须≥2.0×105/ml。结论CD4+CD25+Treg细胞能够对CTL杀伤MNK45胃癌细胞株的活性形成明显抑制,在Treg细胞与CTL作用的相应细胞和免疫学机制中,细胞接触机制占主导地位。 Objective To investigate the effect of enriched CD4^+ CD25^+ T regulatory cells on cytotoxicity of CTL against gastric cancer cell line MNK45 cells in vitro and explore the possible underlying mechanism. Methods After T cells enrichment, MACS separating system was used to sort CD8^+ CTL and CD4^+ CD25^+ Treg from spleen T lymphocytes. The optimal concentration of CTL and the best culture condition were explored by measuring the cytotoxichy of CTL against MNK45 at different doses. Then CD4^+ CD25^+ Treg were added into the culture system or in a separate well in transwell system. The influence of Treg on cytotoxicity of CTL was investigated by counting inactive MNK45 cells. Moreover, the cellular and immunological mechanism which might be involved was analyzed. Results In the culture system, CTL showed significant effect against MNK45 ( P 〈0.01). When 1.0 ml (5.0 × 10^4/ml) was added to this reaction system, the amount of killed MNK45 cells decrease obviously ( P 〈0.05). And when Treg cells were cultured seperatly in the TransWell system, Treg cells must be increased 2.0 × 10^5/ml to achieve the same inhibitory effect. Conclusions CD4^+ CD25^+ T regulatory cells could exert inhibitory effect on CD8^+ CTL killing function in vitro, the cell-to-cell contact mechanism plays important roles in mediating this effect.
出处 《消化外科》 CSCD 2006年第3期197-200,共4页 Journal of Digestive Surgery
基金 国家自然科学基金资助项目(No.30200264) 国家自然科学基金重大项目(No.3993430-2)
关键词 胃肿瘤 调节性T细胞 细胞毒性 T淋巴细胞 MNK45胃癌细胞株 Gastric tumor Regulatory T cells Cytotoxic T lymphocyte MNK45
  • 相关文献

参考文献12

  • 1Kawaida H, Kono K, Takahashi A, et al . Distribution of CD4^+ CD25^high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer[J]. J Surgical Research, 2005,124 ( 1 ) : 151 -157.
  • 2William L G, Daniel A H. The EWS-WT1 gene fusion in desmoplastic small round cell tumor[J]. Seminars in Cancer Biology, 2005,15(3) : 197-205.
  • 3郑峻松,吴军,易绍萱,贺伟峰,陈希炜,解志杰,彭双发.细胞因子及胸腺微环境影响T_(reg)细胞增殖机制研究[J].第三军医大学学报,2003,25(21):1885-1887. 被引量:9
  • 4郑峻松,吴军,黄文华,彭代智,肖光夏,罗中华.严重烫伤对小鼠脾脏T淋巴细胞经TCR_(α/β)、CD28活化通路和T细胞功能的影响[J].第三军医大学学报,2001,23(12):1430-1432. 被引量:5
  • 5Yang Y, Huang C T, Huang X, et al. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance[J]. Nat Immunol,2004,5(5) :508-515.
  • 6Raghavan S, Holmgren J. CD4^+ CD25^+ suppressor T cells regulate pathogen induced inflammation and disease[J]. FEMS Immunol Med Microbiol,2005,44(2) :121-127.
  • 7Subramaniam M, Jeyarani R, Angela M T. Minor histocompatibility antigens: Molecular targets for immunomodulation in tissue transplantation and tumor therapy[J]. Clinical and Applied Immunology Reviews,2005,5(2):95-109.
  • 8Janssens V, Goris J, Van Hoof C. PP2A: the expected tumor suppressor[J]. Current Opinion in Genetics Development, 2005,15(1) :34-41.
  • 9Jonuleit H, Schmitt E, Schuler G, et al . Induction of interleukin 10-producing, nonproliferating CD4^+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells [J]. J Exp Med,2000,192(6):1213-1222.
  • 10Christopher A, Klebanoff H, Khong T, et al . Sinks,suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy[J]. Trends in Immunology,2005;26(2) :111-117.

二级参考文献14

  • 1李翠玲,崔正言,李淑贞.MTT比色分析法的改良及初步应用[J].上海免疫学杂志,1996,16(5):306-307. 被引量:59
  • 2Gavin M A, Clarke S R, Negrou E, et al. Homeostasis and anergy of CD4+ CD25+ suppressor T cells in vitro[J]. Nature Immunology, 2002,3(1):33-41.
  • 3Seddon B, Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity[J]. J Exp Med, 1999, 189(3) : 877 - 882.
  • 4Read S, Mauze S, Asseman C, et al. CD38+ CD45RB^low CD4+ T cells:a population of T cells with immune regulatory activities in vitro[J]. Eur J Immunol, 1998, 28(8) : 3435 - 3447.
  • 5Chai J G, Tsang J Y S, LecHer R, et al. CD4+ CD25+ T cells as immunoregulatory T cells in vitro [ J ]. Eur J Immunol, 2002, 32 ( 8 ) : 2365 -2375.
  • 6Shevach E M. Regulatory T cells in autoimmunity[J]. Ann Rev Immunol,2000,18(3) :423 - 449.
  • 7Seddon B, Mason D. The third function of the thymus[J]. Immunol Today,2000,21(2) :95 - 99.
  • 8hoh M, Takahishi T, Sakaguchi N, et al. Thymus and autoimmunity: production of CD25+ CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunological self-tolerance [ J ]. J Immunol, 1999,162( 11 ) : 5317 - 5326.
  • 9Takahashi T, Kuniyasu Y, Toda M, a al. Immunologic selftolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state[J].Int Immunol, 1998,10(8) : 1969 - 1980.
  • 10Jonuleit H, Schmitt E, Schuler G, et al. Induction of interleukin 10-producing, nonprolifrating CD4+ T cells with regulatroy properties by repetitive stimulation with allogeneic immature human dendritic cells[J]. J Exp Med, 2000,192(6): 1213- 1222.

共引文献11

同被引文献14

  • 1雷晓,雷玉洁,石彦,余佩武,饶芸,钱锋,周立新.胃癌抗原特异性树突状细胞疫苗的抗瘤效应[J].中华实验外科杂志,2004,21(6):755-755. 被引量:3
  • 2雷晓,余佩武,赵永亮,石彦,饶芸,曾冬竹,吴淼,周立新.CD4^+CD25^+调节性T细胞在胃癌患者的表达及其临床意义[J].第三军医大学学报,2006,28(5):397-400. 被引量:9
  • 3Rong-Fu W. Functional control of regulatory T cells and cancer immunotherapy[J] Seminars in Cancer Biology,2006,16 : 106-114.
  • 4Dunn GP,Old LJ,Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol,2004,22 : 329-360.
  • 5Tirapu I ,Calvillo M ,Qian C ,et al. Cytokine gene transfer into dendritic cells for cancer treatment. Curr C, ene Ther,2002 ,2 :79-89.
  • 6Kayagaki N, Yamaguchi N, Nakayama M, et al. Expression and function of TNF2related apoptosis2 inducing ligand on murine activated NK cells. J Immunol, 1999,163 : 1906-1913.
  • 7Screpanti V,Wallin RP,Ljunggren HG,et al. A central role for death receptor mediated apoptosis in the rejection of tumors by NK cells. J Immunol,2001,167 :2068-2073.
  • 8Yang ZZ, Novak AJ,Ziesmer CS, et al. Attenuation of CD8 ( + ) T-cell function by CD4 ( + ) CD25 ( + ) regulatory T cells in B-cell non- Hodgkin ' s lymphoma. Cancer Res ,2006,66 : 10145-10152.
  • 9Seddon B, Mason D. The third function of the thymus. Immunol Today, 2000,21 : 95-99.
  • 10Wang RF. Functional control of regulatory T cells and cancer immunotherapy. Semin Cancer Biol, 16 : 106-114.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部